Pharmanovia, a UK-based pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has confirmed the appointment of YongSeok Choi, who will take the role of General Manager (GM) for Korea and Japan.

With an impressive career spanning over 24 years within the pharmaceutical and biotechnology industry, YongSeok brings an extensive breadth of knowledge and experience in strategy, business management and operations, and product development.

Before joining Pharmanovia, YongSeok was the Chief Executive Officer of BioGraphene Inc, a biotech startup focused on new drug development for neurodegenerative disorders. Prior to this, YongSeok was a Business Development and Strategy Director at Takeda Korea and held various roles at AstraZeneca.

In his new role, YongSeok will be based in Korea and will work closely with Pharmanovia’s global and regional teams, as well as partners in Korea and Japan, to drive the company’s growth and identify new business development opportunities.